{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:03:05Z","timestamp":1791644585387,"version":"4.3.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Open Research Grant of Xinjiang Key Laboratory of Oncology","award":["XJKLO-2023P006"],"award-info":[{"award-number":["XJKLO-2023P006"]}]},{"name":"the Science and Technology Innovation Leadership Program of Xinjiang Uygur Autonomous Region","award":["2023TSYCLJ0041"],"award-info":[{"award-number":["2023TSYCLJ0041"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Female students in tertiary vocational institutions, particularly in regions with limited medical resources, play a crucial role in grassroots healthcare and cervical cancer prevention. Understanding their awareness of human papillomavirus (HPV), willingness to receive the HPV vaccine, and perceived barriers is essential for promoting vaccination equity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cross-sectional study was conducted from March to April 2023 among female vocational students in southern Xinjiang, China, using a standardized electronic questionnaire. The collected data included sociodemographic characteristics, HPV-related knowledge, vaccination willingness, and barriers. Descriptive statistics and logistic regression analyses were performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 1,157 participants, only 37.0% had heard of HPV, and 28.9% were aware of the HPV vaccine. Univariate analysis revealed that non-medical majors and students from rural areas had significantly lower odds of having adequate knowledge (OR\u2009=\u20090.450, 95% CI: 0.360\u20130.563,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001; and OR\u2009=\u20090.458, 95% CI: 0.350\u20130.600,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001; respectively). In contrast, higher parental education (junior college\/bachelor\u2019s degree or above) was associated with 58% greater odds of higher awareness (OR\u2009=\u20091.576, 95% CI: 1.119\u20132.219,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.009). Additionally, students who had not heard of HPV or the HPV vaccine were significantly less likely to possess sufficient awareness (OR\u2009=\u20090.230, 95% CI: 0.181\u20130.293,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001; and OR\u2009=\u20090.194, 95% CI: 0.150\u20130.250,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001; respectively). Further, multivariate analysis confirmed that major, residence, prior HPV awareness, and vaccine awareness were independent predictors of knowledge level (all\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Specifically, medical students demonstrated greater knowledge regarding HPV typing (41.8% vs. 25.6%) and optimal vaccination timing (16.7% vs. 7.9%) than non-medical students. Regarding vaccination attitudes, only 32.1% of the overall students expressed willingness to receive the HPV vaccine, with higher willingness rates observed among medical students (44.6% vs. 19.7%), urban residents (47.8% vs. 27.9%), and individuals who were aware of HPV (50.5%) or the HPV vaccine (59.3%). Actual uptake of HPV vaccine, however, remained low (1.1%\u20134.5%). Regression analysis showed that medical students had 2.4 times higher vaccination intent, and urban residents exhibited 1.7 times higher intent, compared to their counterparts. Furthermore, awareness was positively correlated with willingness to vaccinate, whereas an earlier age at sexual debut was linked to reduced vaccination intent (OR\u2009=\u20090.57, 95% CI: 0.37\u20130.89;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.02). The main barrier to vaccination was the low perceived risk associated with young age (45.4%); medical students reported greater concerns about access and cost, whereas psychological barriers, such as worries about side effects and doubts about safety and efficacy, were common across all groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>HPV awareness and vaccination uptake among female vocational students in southern Xinjiang remain low. Targeted health education initiatives should focus on non-medical students, rural populations, and individuals from lower socioeconomic backgrounds. Enhancing vaccine accessibility and affordability through institutional and governmental efforts is critical to improving vaccination coverage in this population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12889-025-25209-3","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T13:17:50Z","timestamp":1764767870000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["HPV vaccine knowledge gaps and vaccination intent: a cross-sectional study of vocational students in Southern Xinjiang of China in 2023"],"prefix":"10.1186","volume":"26","author":[{"given":"Guligeina","family":"Abudurexiti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kadeliya","family":"Muhetaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zikereya","family":"Saimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumei","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huilin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paizilaiti","family":"Yilamujiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nafeisha","family":"Adili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigeerayi","family":"Nuermaimaiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guzhalinuer","family":"Abulizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remila","family":"Rezhake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"issue":"3","key":"25209_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"25209_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-019-6487-9","volume":"19","author":"Y Ge","year":"2019","unstructured":"Ge Y, Zhong S, Ren M, et al. Prevalence of human papillomavirus infection of 65,613 women in East China. BMC Public Health. 2019;19:178.","journal-title":"BMC Public Health"},{"issue":"1","key":"25209_CR3","doi-asserted-by":"publisher","first-page":"49","DOI":"10.4103\/ijpvm.IJPVM_444_17","volume":"9","author":"E Haghir","year":"2018","unstructured":"Haghir E, Madampage C, Mahmood R, et al. Risk factors associated with self-reported sexually transmitted infections among postsecondary students in Canada. Int J Prev Med. 2018;9:49.","journal-title":"Int J Prev Med"},{"key":"25209_CR4","doi-asserted-by":"crossref","unstructured":"Thompson AB, Flowers LC. Human papillomavirus (HPV). In: Sexually Transmitted Infections in Adolescence and Young Adulthood: A Practical Guide for Clinicians. 2020:279\u2013297.","DOI":"10.1007\/978-3-030-20491-4_18"},{"issue":"10","key":"25209_CR5","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1016\/j.molonc.2015.10.018","volume":"9","author":"MH Geukes Foppen","year":"2015","unstructured":"Geukes Foppen MH, Donia M, Svane IM, et al. Tumor-infiltrating lymphocytes for the treatment of metastatic cancer. Mol Oncol. 2015;9(10):1918\u201335.","journal-title":"Mol Oncol"},{"issue":"7","key":"25209_CR6","first-page":"1107","volume":"46","author":"Chinese Preventive Medicine Association, Vaccine and Immunization Branch of Chinese Preventive Medicine Association","year":"2025","unstructured":"Chinese Preventive Medicine Association, Vaccine and Immunization Branch of Chinese Preventive Medicine Association. Expert consensus on immunoprophylaxis of human Papillomavirus-Related diseases such as cervical cancer (2025 Version) [J]. Chin J Epidemiol. 2025;46(7):1107\u201341.","journal-title":"Chin J Epidemiol"},{"issue":"19","key":"25209_CR7","doi-asserted-by":"publisher","first-page":"413","DOI":"10.46234\/ccdcw2024.080","volume":"6","author":"J Chen","year":"2024","unstructured":"Chen J, Zhang Z, Pan W, et al. Estimated human papillomavirus vaccine coverage among females 9\u201345 years of age - China, 2017\u20132022. China CDC Wkly. 2024;6(19):413\u20137.","journal-title":"China CDC Wkly"},{"key":"25209_CR8","doi-asserted-by":"crossref","unstructured":"Ji M, Huang Z, Yan H, et al. HPV vaccination coverage, hesitancy, and barriers: insights from a serial cross-sectional study in Shanghai, China (2019\u20132024)[J]. Volume 21. Human Vaccines & Immunotherapeutics; 2025. p. 2513707. 1.","DOI":"10.1080\/21645515.2025.2513707"},{"issue":"8","key":"25209_CR9","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1080\/21645515.2021.1899731","volume":"17","author":"G Yin","year":"2021","unstructured":"Yin G, Zhang Y, Chen C, et al. Have you ever heard of human papillomavirus (HPV) vaccine? The awareness of HPV vaccine for college students in China based on meta-analysis. Hum Vaccin Immunother. 2021;17(8):2736\u201347.","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"25209_CR10","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2024.2315653","volume":"20","author":"J An","year":"2024","unstructured":"An J, Liu Y, Ma Y, et al. Real-world data of China: analysis of HPV vaccine coverage and post-vaccination adverse reaction monitoring in Western Chinese provinces from 2018 to 2021. Hum Vaccin Immunother. 2024;20(1):2315653.","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"25209_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-11291-5","volume":"15","author":"K Muhetaer","year":"2025","unstructured":"Muhetaer K, Abulimiti T, Abuduxikuer G, et al. HPV vaccine awareness and acceptance among rural women in Xinjiang, China. Sci Rep. 2025;15(1):25515.","journal-title":"Sci Rep"},{"issue":"4","key":"25209_CR12","first-page":"795","volume":"24","author":"EQ Wu","year":"2013","unstructured":"Wu EQ, Liu B, Cui JF, et al. Prevalence of type-specific human papillomavirus and pap results in Chinese women: a multi-center, population-based cross-sectional study. Cancer Causes Control. 2013;24(4):795\u2013803.","journal-title":"Cancer Causes Control"},{"issue":"3","key":"25209_CR13","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.3892\/ol.2020.11754","volume":"20","author":"R Hull","year":"2020","unstructured":"Hull R, Mbele M, Makhafola T, et al. Cervical cancer in low and middle-income countries. Oncol Lett. 2020;20(3):2058\u201374.","journal-title":"Oncol Lett"},{"key":"25209_CR14","unstructured":"World Health Organization. Global Strategy to Accelerate the Elimination of Cervical Cancer as a Public Health Problem. 2020."},{"issue":"3","key":"25209_CR15","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1080\/21645515.2020.1797368","volume":"17","author":"C Deng","year":"2021","unstructured":"Deng C, Chen X, Liu Y. Human papillomavirus vaccination: coverage rate, knowledge, acceptance, and associated factors in college students in Mainland China. Hum Vaccin Immunother. 2021;17(3):828\u201335.","journal-title":"Hum Vaccin Immunother"},{"issue":"9","key":"25209_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0003273","volume":"4","author":"J Rume","year":"2024","unstructured":"Rume J, Morhason-Bello IO, Oladokun A. Assessment of knowledge of human papillomavirus transmission and prevention among tertiary institution students in the Plateau Central Senatorial District, Nigeria. PLOS Glob Public Health. 2024;4(9):e0003273.","journal-title":"PLOS Glob Public Health"},{"key":"25209_CR17","doi-asserted-by":"publisher","DOI":"10.1177\/10732748211032899","volume":"28","author":"M Si","year":"2021","unstructured":"Si M, Jiang Y, Su X, et al. Willingness to accept human papillomavirus vaccination and its influencing factors using information-motivation-behavior skills model: a cross-sectional study of female college freshmen in mainland China. Cancer Control. 2021;28:10732748211032899.","journal-title":"Cancer Control"},{"issue":"7","key":"25209_CR18","doi-asserted-by":"publisher","first-page":"e0271222","DOI":"10.1371\/journal.pone.0271222","volume":"17","author":"N El Mansouri","year":"2022","unstructured":"El Mansouri N, Ferrera L, Kharbach A, et al. Awareness and knowledge associated with human papillomavirus infection among university students in morocco: A cross-sectional study. PLoS ONE. 2022;17(7):e0271222.","journal-title":"PLoS ONE"},{"issue":"12","key":"25209_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11121850","volume":"11","author":"D Pruski","year":"2023","unstructured":"Pruski D, Millert-Kali\u0144ska S, Haraj J, et al. Knowledge of HPV and HPV vaccination among Polish students from medical and non-medical universities. Vaccines. 2023;11(12):1850.","journal-title":"Vaccines"},{"key":"25209_CR20","volume":"17","author":"J Huber","year":"2021","unstructured":"Huber J, Mueller A, Sailer M, et al. Human papillomavirus persistence or clearance after infection in reproductive age. What is the status? Review of the literature and new data of a vaginal gel containing silicate dioxide, citric acid, and selenite. Womens Health. 2021;17:17455065211020702.","journal-title":"Womens Health"},{"issue":"3","key":"25209_CR21","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s00404-011-2155-8","volume":"285","author":"K Vinodhini","year":"2012","unstructured":"Vinodhini K, Shanmughapriya S, Das BC, et al. Prevalence and risk factors of HPV infection among women from various provinces of the world. Arch Gynecol Obstet. 2012;285(3):771\u20137.","journal-title":"Arch Gynecol Obstet"},{"issue":"10","key":"25209_CR22","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1080\/21645515.2021.1927411","volume":"17","author":"Y Ma","year":"2021","unstructured":"Ma Y, Wang C, Liu F, et al. Human papillomavirus vaccination coverage and knowledge, perceptions and influencing factors among university students in Guangzhou, China. Hum Vaccin Immunother. 2021;17(10):3603\u201312.","journal-title":"Hum Vaccin Immunother"},{"issue":"5","key":"25209_CR23","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.vaccine.2009.12.063","volume":"29","author":"SL Rosenthal","year":"2011","unstructured":"Rosenthal SL, Weiss TW, Zimet GD, et al. Predictors of HPV vaccine uptake among women aged 19\u201326: importance of a physician\u2019s recommendation. Vaccine. 2011;29(5):890\u20135.","journal-title":"Vaccine"},{"key":"25209_CR24","unstructured":"Hung MC, Williams WW, Lu PJ et al. Vaccination coverage among adults in the United States, National Health Interview Survey, 2017. Centers for Disease Control and Prevention. 2018."},{"issue":"12","key":"25209_CR25","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.15419\/bmrat.v4i12.386","volume":"4","author":"Z Momenimovahed","year":"2017","unstructured":"Momenimovahed Z, Salehiniya H. Incidence, mortality and risk factors of cervical cancer in the world. Biomed Res Ther. 2017;4(12):1795\u2013811.","journal-title":"Biomed Res Ther"},{"issue":"1","key":"25209_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12978-022-01444-4","volume":"19","author":"GN Mihretie","year":"2022","unstructured":"Mihretie GN, Liyeh TM, Ayele AD, et al. Knowledge and willingness of parents towards child girl HPV vaccination in Debre Tabor Town, Ethiopia: a community-based cross-sectional study. Reprod Health. 2022;19(1):136.","journal-title":"Reprod Health"},{"issue":"11","key":"25209_CR27","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.3390\/vaccines12111286","volume":"12","author":"R Zha","year":"2024","unstructured":"Zha R, Liao C, Lin D, et al. A comprehensive evaluation of the HPV neutralizing antibodies in Guangzhou, china: A comparative study on various HPV vaccines. Vaccines (Basel). 2024;12(11):1286. Published 2024 Nov 17.","journal-title":"Vaccines (Basel)"},{"issue":"7\u20138","key":"25209_CR28","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1080\/21645515.2018.1564436","volume":"15","author":"E Karafillakis","year":"2019","unstructured":"Karafillakis E, Simas C, Jarrett C, et al. HPV vaccination in a context of public mistrust and uncertainty: a systematic literature review of determinants of HPV vaccine hesitancy in Europe. Hum Vaccin Immunother. 2019;15(7\u20138):1615\u201327.","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"25209_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12020127","volume":"12","author":"T Achima\u0219-Cadariu","year":"2024","unstructured":"Achima\u0219-Cadariu T, Pa\u0219ca A, Jiboc NM, et al. Vaccine hesitancy among European parents\u2014psychological and social factors influencing the decision to vaccinate against HPV: a systematic review and meta-analysis. Vaccines. 2024;12(2):127.","journal-title":"Vaccines"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-25209-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-25209-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-25209-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T13:42:56Z","timestamp":1767793376000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12889-025-25209-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["25209"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-25209-3","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,3]]},"assertion":[{"value":"8 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and approved by the Ethics Committee of the Third Clinical College of Xinjiang Medical University (approval No. K-2021064).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read the manuscript and approved the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"102"}}